MarketAnalysisMarketAnalysis
NYSE:BSX

Boston Scientific Corporation - NYSE:BSX - Comprehensive analysis

Free evaluation through quantitative algorithms Boston Scientific Corporation - NYSE:BSX

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

17.61

Market

91

Sector

73

Gross Profit Growth Over Prior Year

16.33

Market

85

Sector

71

EBITDA Growth Over Prior Year

18.21

Market

78

Sector

73

EBITA Growth Over Prior Year

18.89

Market

78

Sector

67

EBIT Growth Over Prior Year

24.2

Market

83

Sector

70

Earnings from Cont. Ops. Growth Over Prior Year

15.95

Market

64

Sector

54

Net Income Growth Over Prior Year

16.38

Market

65

Sector

57

Normalized Net Income Growth Over Prior Year

30.7

Market

83

Sector

67

Diluted EPS before Extra Growth Over Prior Year

16.82

Market

65

Sector

56

A/R Growth Over Prior Year

14.81

Market

84

Sector

76

Inventory Growth Over Prior Year

13.12

Market

91

Sector

84

PPE Net Growth Over Prior Year

13.52

Market

85

Sector

80

Total Assets Growth Over Prior Year

12.12

Market

86

Sector

70

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

12.9

Market

73

Sector

70

Cash from Ops. Growth Over Prior Year

37.2

Market

90

Sector

73

CAPEX Growth Over Prior Year

11.11

Market

68

Sector

73

Dividend per Share Growth Over Prior Year

0

Market

36

Sector

48

Levered Free Cash Flow Growth Over Prior Year

-3.85

Market

35

Sector

31

Unlevered Free Cash Flow Growth Over Prior Year

-2.32

Market

36

Sector

31

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

69

Market

83

Sector

69

SG&A Margin %

35.7

Market

88

Sector

47

EBITDA Margin %

25.5

Market

52

Sector

88

EBITA Margin %

23

Market

62

Sector

89

EBIT Margin %

17.93

Market

48

Sector

89

Earnings from Cont. Ops Margin %

11.02

Market

42

Sector

87

Net Income Margin %

11.07

Market

41

Sector

88

Net Income Avail. for Common Margin %

11.06

Market

43

Sector

88

Normalized Net Income Margin %

10.34

Market

50

Sector

88

Levered Free Cash Flow Margin %

10.79

Market

54

Sector

80

Unlevered Free Cash Flow Margin %

11.93

Market

52

Sector

78

Return on Assets %

5.03

Market

48

Sector

84

Return on Capital %

6.02

Market

38

Sector

83

Return on Equity %

8.89

Market

26

Sector

84

Return on Common Equity %

9.03

Market

26

Sector

84

Total Asset Turnover

0.45

Market

43

Sector

59

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 24
Momentum: 76
Growth: 72
Profitability: 50

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

8.94

Market

86

Sector

78

TEV/LTM EBITDA

34.3

Market

95

Sector

91

P/LTM Normalized EPS

84

Market

94

Sector

91

P/BV

6.57

Market

72

Sector

86

TEV/LTM Unlevered FCF

75

Market

97

Sector

95

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-2.97

Market

57

Sector

75

3M Price Performance

-0.36

Market

63

Sector

82

6M Price Performance

9.36

Market

83

Sector

83

9M Price Performance

21.3

Market

85

Sector

88

1Y Price Performance

36.9

Market

91

Sector

90

Start analyzing Boston Scientific Corporation - NYSE:BSX with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports